Pacira Pharmaceuticals Inc (PCRX)

NASDAQ
62.21
+0.75(+1.22%)
After Hours
62.21
0.00(0.00%)
- Real-time Data
  • Volume:
    297,602
  • Bid/Ask:
    53.10/70.00
  • Day's Range:
    61.00 - 62.68

PCRX Overview

Prev. Close
61.46
Day's Range
61 - 62.68
Revenue
442.98M
Open
61.5
52 wk Range
40.96 - 80
EPS
3.32
Volume
297,602
Market Cap
2.74B
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
441,458
P/E Ratio
18.53
Beta
1.1
1-Year Change
50.05%
Shares Outstanding
44,025,456
Next Earnings Date
Aug 05, 2021
What is your sentiment on Pacira Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Pacira Pharmaceuticals Inc News

Pacira Pharmaceuticals Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuySellBuy
Technical IndicatorsBuyStrong BuyStrong BuySellStrong Buy
SummaryBuyStrong BuyStrong BuySellStrong Buy

Pacira Pharmaceuticals Inc Company Profile

Pacira Pharmaceuticals Inc Company Profile

Employees
624

Pacira BioSciences, Inc., formerly Pacira Pharmaceuticals, Inc. is a holding company. The Company is a pharmaceutical company focused on the development, manufacture and commercialization of pharmaceutical products, based on its DepoFoam extended release drug delivery technology, for use primarily in hospitals and ambulatory surgery centers. Its lead product candidate is EXPAREL (bupivacaine liposome injectable suspension), which consists of bupivacaine, an amide-type local anesthetic, encapsulated in DepoFoam and is indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. In addition to EXPAREL, DepoFoam is also the basis for its other Food and Drug Administration-approved commercial product, DepoCyt(e), which it manufactures for its commercial partners, as well as its product candidates. The Company's other product candidates include DepoMeloxicam (DepoMLX) and DepoTranexamic Acid (DepoTXA).

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.